Genfit Sa share price today

(GNFT)

Genfit Sa share price is $3.8 & ₹322.91 as on 21 Dec 2024, 2.30 'hrs' IST

$3.8

▲

0.08

(2.15%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Genfit Sa share price in Dollar and Rupees. Guide to invest in Genfit Sa from India. Also see the sentimental analysis on Indian investors investing in Genfit Sa. Get details on the Indian mutual funds that are investing in Genfit Sa. Get Analyst recommendations and forecasts along with all the Genfit Sa's financials.

Genfit Sa share price movements

Today's Low: $3.70
Today's High: $3.80
$3.80
2.63%
Downside
Day's Volatility :2.63%
Upside
0.0%
52 Weeks Low: $3.31
52 Weeks High: $6.42
$3.80
12.89%
Downside
52 Weeks Volatility :48.47%
Upside
40.84%

Genfit Sa Returns

Period	Genfit Sa	Index (Russel 2000)
3 Months	-23.85%	0.0%
6 Months	-3.31%	0.0%
1 Year	0.53%	0.0%
3 Years	-32.5%	-19.7%

Genfit Sa Key Statistics

in dollars & INR

Previous Close	$3.72
Open	$3.71
Today's High	$3.8
Today's Low	$3.7
Market Capitalization	$185.7M
Today's Volume	$3.2K
52 Week High	$6.4229
52 Week Low	$3.31
Revenue TTM	$80.5M
EBITDA	$21.9M
Earnings Per Share (EPS)	$0.39
PE Ratio	9.54
Profit Margin	27.68%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	25.91%

How to invest in Genfit Sa from India?

It is very easy for Indian residents to invest directly in Genfit Sa from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Genfit Sa stock in both Indian Rupees (INR) and US Dollars (USD). Search for Genfit Sa or GNFT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Genfit Sa or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Genfit Sa shares which would translate to 0.224 fractional shares of Genfit Sa as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Genfit Sa, in just a few clicks!

Returns in Genfit Sa for Indian investors in Rupees

Investment Value

₹1,00,000

Genfit Sa investment value today

Current value as on today

₹1,02,725

Returns

₹2,725

(+2.73%)

Returns from Genfit Sa Stock

₹529 (+0.53%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Genfit Sa

363%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Genfit Sa on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 363% more investors are searching Genfit Sa in the last 30 days versus the previous period.

Global Institutional Holdings in Genfit Sa

Optiver Holding B.V.
0.10%
Morgan Stanley - Brokerage Accounts
0.05%

Analyst Recommendation on Genfit Sa

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Genfit Sa(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Genfit Sa

What analysts predicted

Upside of 165.39%

Current:

$3.80

Target:

$10.09

Insights on Genfit Sa

Price Movement
In the last 3 months, GNFT stock has moved down by -21.5%
Increasing Revenue
Revenue is up for the last 4 quarters, 2.81M → 61.10M (in $), with an average increase of 59.2% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -8.03M → 30.31M (in $), with an average increase of 101.5% per quarter
GNFT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 31.1%
GNFT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 51.3%
Price to Sales
ForGNFT every $1 of sales, investors are willing to pay $2.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Genfit Sa Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$69.0K	↓ 41.53%
Net Income	$-79.5M	↑ 35.69%
Net Profit Margin	-115.2K%	↓ 65583.42%

	FY19	Y/Y Change
Revenue	$30.8M	↑ 44594.2%
Net Income	$-65.1M	↓ 18.08%
Net Profit Margin	-211.24%	↑ 115036.59%

	FY20	Y/Y Change
Revenue	$765.0K	↓ 97.52%
Net Income	$-101.2M	↑ 55.38%
Net Profit Margin	-13.2K%	↓ 13020.26%

	FY21	Y/Y Change
Revenue	$80.1M	↑ 10366.54%
Net Income	$67.3M	↓ 166.45%
Net Profit Margin	84.0%	↑ 13315.5%

	FY22	Y/Y Change
Revenue	$20.2M	↓ 74.78%
Net Income	$-23.7M	↓ 135.27%
Net Profit Margin	-117.45%	↓ 201.45%

	FY23	Y/Y Change
Revenue	$28.6M	↑ 41.45%
Net Income	$-28.9M	↑ 21.81%
Net Profit Margin	-101.15%	↑ 16.3%

	Q1 FY23	Q/Q Change
Revenue	$7.6M	↑ 23.97%
Net Income	$-10.4M	-
Net Profit Margin	-138.0%	-

	Q2 FY23	Q/Q Change
Revenue	$11.5M	↑ 51.96%
Net Income	$-20.9M	↑ 100.0%
Net Profit Margin	-181.62%	↓ 43.62%

	Q3 FY23	Q/Q Change
Revenue	$2.8M	↓ 75.46%
Net Income	$-4.0M	↓ 80.72%
Net Profit Margin	-142.65%	↑ 38.97%

	Q4 FY23	Q/Q Change
Revenue	$17.1M	↑ 506.21%
Net Income	$-8.0M	↑ 100.0%
Net Profit Margin	-47.06%	↑ 95.59%

	Q1 FY24	Q/Q Change
Revenue	$30.6M	↑ 78.84%
Net Income	$15.2M	↓ 288.5%
Net Profit Margin	49.61%	↑ 96.67%

	Q2 FY24	Q/Q Change
Revenue	$61.1M	↑ 100.0%
Net Income	$30.3M	↑ 100.0%
Net Profit Margin	49.61%	↑ 0.0%

	FY18	Y/Y Change
Profit	$-1.8M	↓ 15.44%

	FY19	Y/Y Change
Profit	$30.8M	↓ 1827.68%

	FY20	Y/Y Change
Profit	$563.0K	↓ 98.17%

	FY21	Y/Y Change
Profit	$79.9M	↑ 14093.25%

	FY22	Y/Y Change
Profit	$19.9M	↓ 75.04%

	FY23	Y/Y Change
Profit	$28.2M	↑ 41.49%

	Q1 FY23	Q/Q Change
Profit	$7.6M	-

	Q2 FY23	Q/Q Change
Profit	$15.1M	↑ 100.0%

	Q3 FY23	Q/Q Change
Profit	$2.8M	↓ 81.35%

	Q4 FY23	Q/Q Change
Profit	$17.1M	↑ 506.21%

	Q1 FY24	Q/Q Change
Profit	$30.6M	↑ 78.84%

	Q2 FY24	Q/Q Change
Profit	$60.2M	↑ 97.18%

	FY18	Y/Y Change
Operating Cash Flow	$-56.1M	↑ 12.49%
Investing Cash Flow	$-4.0M	↑ 35.21%
Financing Cash Flow	$-6.5M	↓ 103.74%

	FY19	Y/Y Change
Operating Cash Flow	$-47.7M	↓ 14.98%
Investing Cash Flow	$327.0K	↓ 108.2%
Financing Cash Flow	$116.9M	↓ 1893.98%

	FY20	Y/Y Change
Operating Cash Flow	$-96.4M	↑ 102.12%
Investing Cash Flow	$-966.0K	↓ 395.41%
Financing Cash Flow	$-8.3M	↓ 107.06%

	FY21	Y/Y Change
Operating Cash Flow	$99.9M	↓ 203.68%
Investing Cash Flow	$-3.4M	↑ 249.59%
Financing Cash Flow	$-8.9M	↑ 7.99%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-12.5M	↓ 52.04%
Investing Cash Flow	$1.3M	↑ 0.0%
Financing Cash Flow	$-882.0K	↑ 5.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-25.8M	↑ 106.13%
Investing Cash Flow	$1.3M	↑ 0.0%
Financing Cash Flow	$-995.0K	↑ 12.81%

Genfit Sa Technicals Summary

Sell

Neutral

Buy

Genfit Sa is currently in a neutral trading position according to technical analysis indicators.

Genfit Sa Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Genfit Sa	-10.38%	-3.31%	0.53%	-32.5%	-79.12%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Genfit Sa	9.54	9.54	NA	0.58	0.26	0.07	NA	1.96
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Genfit Sa	Buy	$185.7M	-79.12%	9.54	27.68%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Genfit Sa

genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver (such as nash - nonalcoholic steatohepatitis) or the bowel (such as the inflammatory bowel disease). genfit is committed to contribute to bringing new medicines to market for patients who lack suitable solutions, and strives to implement mutually beneficial approaches that combine novel drugs and biomarkers. its research programs have resulted in the creation of a rich and diversified pipeline of drug candidates, including genfit’s lead proprietary compound, gft505, that is completing a phase 2b study in nash.

Organization	Genfit Sa
Employees	169
CEO	Mr. Jean-Francois Mouney
Industry	Biotechnology

Management People of Genfit Sa

Name	Title
Mr. Jean-Francois Mouney	Co-Founder & Chairman of the Board
Mr. M. Pascal Prigent	Chief Executive Officer
Prof. Bart Staels	Co-Founder & Chairman of the Scientific Advisory Board
Mr. Thomas Baetz	Chief Financial Officer
Mr. Pascal Caisey	Chief Operating Officer
Dr. Meriam Kabbaj Ph.D.	Chief Technology Officer
Dr. Dean W. Hum Ph.D.	Chief Scientific Officer
Mr. Jean-Christophe Marcoux	Chief Corporate Affairs Officer, Head of Investor Relations & Head of ESG
Mr. Laurent Lannoo	Corporate Secretary & Director of Legal Affairs
Ms. Stefanie Magner J.D.	Chief Compliance Officer & Executive VP of International Legal Affairs

Important FAQs about investing in Genfit Sa from India :

What is Genfit Sa share price today?

Genfit Sa share price today stands at $3.80, Open: $3.71 ; Previous Close: $3.72 ; High: $3.80 ; Low: $3.70 ; 52 Week High: $6.42 ; 52 Week Low: $3.31. The stock opens at $3.71, after a previous close of $3.72. The stock reached a daily high of $3.80 and a low of $3.70, with a 52-week high of $6.42 and a 52-week low of $3.31.

Can Indians buy Genfit Sa shares?

Yes, Indians can invest in the Genfit Sa (GNFT) from India.

With INDmoney, you can buy Genfit Sa at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Genfit Sa at zero transaction cost.

How can I buy Genfit Sa shares from India?

It is very easy to buy Genfit Sa from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Genfit Sa be purchased?

Yes, you can buy fractional shares of Genfit Sa with INDmoney app.

What are the documents required to start investing in Genfit Sa stocks?

To start investing in Genfit Sa, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.